Table 2 Anthropometric, clinical, and biochemical parameters of the study population by MetS
Variables | With MetS (n) | Median (p25–p75) or % (95% CI) | Without MetS (n) | Median (p25–p75) or % (95% CI) | Total | Median or % (95% CI) |
|---|---|---|---|---|---|---|
Waist circumference | 175 | 95 (88–102) | 116 | 90 (84–84.5) | 291 | 93 (92–95) |
< 80 cm | 2 | 1.1 (a) | 20 | 17.2 (11.2–24.9) | 22 | 7.6 (4.9–11) |
≥ 80 cm | 173 | 98.9 (96.4–99.8) | 96 | 82.8 (75.1–88.8) | 269 | 92.4 (89.0–95.1) |
BMI | 175 | 30.7 (28.1–33.9) | 116 | 28.1 (25.2–30.1) | 291 | 29.7 (26.8.0–32.3) |
< 25 kg/m2 | 7 | 4.0 (1.8–7.7) | 27 | 23.3 (16.3–31.6) | 34 | 11.7 (8.4–15.7) |
≥ 25 kg/m2 | 168 | 96.0 (92.3–98.2) | 89 | 76.7 (68.4–83.7) | 257 | 88.3 (84.3–91.6) |
Blood pressure | ||||||
SBP | 175 | 124 (115–139) | 116 | 115 (108–122) | 291 | 120 (111–132) |
DBP | 175 | 76 (68–83) | 116 | 70.5 (66–75) | 291 | 74 (67–80) |
SBP < 130/DBP < 85 mm Hg | 90 | 51.4 (44.1–58.8) | 108 | 93.1 (87.4–96.7) | 198 | 68.0 (62.5–73.2) |
SBP ≥ 130/DBP ≥ 85 mm Hg | 85 | 48.6 (41.2–55.9) | 8 | 6.9 (3.3–12.6) | 93 | 32.0 (26.8–37.5) |
Triglycerides | 175 | 201 (166–283) | 116 | 123 (96–149) | 291 | 174 (126–228) |
< 150 mg/dL | 22 | 12.6 (8.3–18.1) | 90 | 77.6 (69.4–84.4) | 112 | 38.5 (33.0–44.2) |
≥ 150 mg/dL | 153 | 87.4 (81.9–91.7) | 26 | 22.4 (15.6–30.6) | 179 | 61.5 (55.8–67.0) |
HDL-c | 175 | 42.5 (37.9–48.1) | 116 | 50.1 (40.4–55.1) | 291 | 44.3 (38.9–51.2) |
≥ 50 mg/dL | 26 | 14.9 (10.2–20.7) | 60 | 51.7 (42.7–60.7) | 86 | 29.6 (24.5–35.0) |
< 50 mg/dL | 149 | 85.1 (79.3–89.8) | 56 | 48.3 (39.3–57.3) | 205 | 70.4 (65.0–75.5) |
Glucose | 175 | 92 (83.5–104) | 116 | 83 (76–89.5) | 291 | 88.0 (80.5–97.5) |
< 100 mg/dL | 118 | 67.4 (60.2–74.0) | 110 | 94.8 (89.7–97.8) | 228 | 78.4 (73.4–82.8) |
≥ 100 mg/dL | 57 | 32.6 (26.0–39.8) | 6 | 5.2 (2.2–10.3) | 63 | 21.6 (17.2–26.6) |